HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction
- PMID: 16849330
- PMCID: PMC2892265
- DOI: 10.1074/jbc.M601128200
HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction
Abstract
Nef is an HIV-1 virulence factor that promotes viral pathogenicity by altering host cell signaling pathways. Nef binds several members of the Src kinase family, and these interactions have been implicated in the pathogenesis of HIV/AIDS. However, the direct effect of Nef interaction on Src family kinase (SFK) regulation and activity has not been systematically addressed. We explored this issue using Saccharomyces cerevisiae, a well defined model system for the study of SFK regulation. Previous studies have shown that ectopic expression of c-Src arrests yeast cell growth in a kinase-dependent manner. We expressed Fgr, Fyn, Hck, Lck, Lyn, and Yes as well as c-Src in yeast and found that each kinase was active and induced growth suppression. Co-expression of the negative regulatory kinase Csk suppressed SFK activity and reversed the growth-inhibitory effect. We then co-expressed each SFK with HIV-1 Nef in the presence of Csk. Nef strongly activated Hck, Lyn, and c-Src but did not detectably affect Fgr, Fyn, Lck, or Yes. Mutagenesis of the Nef PXXP motif essential for SH3 domain binding greatly reduced the effect of Nef on Hck, Lyn, and c-Src, suggesting that Nef activates these Src family members through allosteric displacement of intramolecular SH3-linker interactions. These data show that Nef selectively activates Hck, Lyn, and c-Src among SFKs, identifying these kinases as proximal effectors of Nef signaling and potential targets for anti-HIV drug discovery.
Figures









Similar articles
-
Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo.Biochemistry. 2000 Jan 25;39(3):489-95. doi: 10.1021/bi992504j. Biochemistry. 2000. PMID: 10642173
-
The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.Virology. 1998 Aug 1;247(2):200-11. doi: 10.1006/viro.1998.9244. Virology. 1998. PMID: 9705913
-
Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment.J Biol Chem. 2014 Oct 10;289(41):28539-53. doi: 10.1074/jbc.M114.600031. Epub 2014 Aug 13. J Biol Chem. 2014. PMID: 25122770 Free PMC article.
-
Src family kinases: regulation of their activities, levels and identification of new pathways.Biochim Biophys Acta. 2008 Jan;1784(1):56-65. doi: 10.1016/j.bbapap.2007.08.012. Epub 2007 Aug 22. Biochim Biophys Acta. 2008. PMID: 17905674 Review.
-
Interactions of the HIV/SIV pathogenicity factor Nef with SH3 domain-containing host cell proteins.Curr HIV Res. 2011 Oct;9(7):531-42. doi: 10.2174/157016211798842107. Curr HIV Res. 2011. PMID: 22103837 Review.
Cited by
-
An integrative approach for a network based meta-analysis of viral RNAi screens.Algorithms Mol Biol. 2015 Feb 13;10:6. doi: 10.1186/s13015-015-0035-7. eCollection 2015. Algorithms Mol Biol. 2015. PMID: 25691914 Free PMC article.
-
Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action.Mol Biol Cell. 2010 Oct 1;21(19):3279-92. doi: 10.1091/mbc.E10-05-0470. Epub 2010 Aug 11. Mol Biol Cell. 2010. PMID: 20702582 Free PMC article.
-
Identification of Novel Subcellular Localization and Trafficking of HIV-1 Nef Variants from Reference Strains G (F1.93.HH8793) and H (BE.93.VI997).Viruses. 2018 Sep 13;10(9):493. doi: 10.3390/v10090493. Viruses. 2018. PMID: 30217018 Free PMC article.
-
Motif mediated protein-protein interactions as drug targets.Cell Commun Signal. 2016 Mar 2;14:8. doi: 10.1186/s12964-016-0131-4. Cell Commun Signal. 2016. PMID: 26936767 Free PMC article. Review.
-
An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259.Oncogene. 2008 Nov 27;27(56):7055-69. doi: 10.1038/onc.2008.330. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794796 Free PMC article.
References
-
- Fackler OT, Baur AS. Immunity. 2002;16:493–497. - PubMed
-
- Peter F. Immunity. 1998;9:433–437. - PubMed
-
- Joseph AM, Kumar M, Mitra D. Curr HIV Res. 2005;3:87–94. - PubMed
-
- Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC. Science. 1992;258:1938–1941. - PubMed
-
- Kestler HW, III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. Cell. 1991;65:651–662. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous